Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Matrix metalloproteinase (MMP) inhibitors block zinc endopeptidases that degrade collagen and other matrix proteins. The first such activity, a collagenase, was detected in amphibian tissue culture in 1962. MMPs remodel tissue during development and wound repair, and they help tumor cells invade surrounding matrix. Membrane type 1 MMP (MT1-MMP, MMP-14), described in 1994, is anchored on the surface of invasive tumor cells. Batimastat, marimastat and GM 6001 are hydroxamate compounds that chelate the catalytic zinc and inhibit a wide range of MMPs. More selective tools include NSC 405020 for MT1-MMP and T-26c for MMP-13. Metalloproteases of the related ADAM family are listed in the neighboring ADAMs category.
MMP-13-IN-1 is a potent and selective inhibitor of matrix metalloproteinase-13 (MMP-13), exhibiting an IC50 value of 16 nM. This compound demonstrates significant inhibitory activity, making it a valuable tool for studying the role of MMP-13 in various pathological processes, including atherosclerosis. Researchers can utilize MMP-13-IN-1 to explore its therapeutic potential in conditions related to extracellular matrix remodeling.
Out of stock
All 3 sizes
MMP13-IN-4 is a selective inhibitor of matrix metalloproteinase-13 (MMP-13) with an IC50 of 14.6 μM. This compound demonstrates significant activity in modulating the enzymatic activity associated with osteoarthritis (OA). MMP13-IN-4 is a valuable tool for research focused on understanding the role of MMP-13 in pathological conditions and developing therapeutic strategies for osteoarthritis.
ABT-518 is a matrix metalloproteinase (MMP) inhibitor that demonstrates significant anti-tumor activity. It exhibits potent inhibition of gelatinase A and B, which are key enzymes involved in tumor growth and metastasis. This compound is valuable for research focused on cancer biology, particularly in studies aimed at understanding and disrupting the metastatic process.
RJF02215 is an MMP-9 inhibitor that demonstrates growth-inhibitory activity on the ovarian cancer SKOV3 cell line. This compound is suitable for use in tumor research, allowing for studies on the role of matrix metalloproteinase-9 in cancer progression and therapy resistance. Its selective inhibition of MMP-9 may provide insights into the molecular mechanisms underlying ovarian cancer proliferation and metastasis.
Out of stock
All 3 sizes
F81-1144b is an inhibitor of matrix metalloproteinases MMP-1 and MMP-3, exhibiting IC50 values of 5 nM and 29 nM, respectively. This compound effectively reduces serum and hepatic triacylglycerol levels, diminishes very-low-density lipoprotein-triacylglycerol secretion, and inhibits de novo hepatic fatty acid synthesis. Additionally, F81-1144b lowers serum insulin and glucose levels, making it a valuable reagent for research related to hypertriglyceridemia and metabolic disorders.
XL-784 free base is a selective inhibitor of matrix metalloproteinases (MMPs), demonstrating potent inhibition with IC50 values of approximately 1900 nM for MMP-1, 0.81 nM for MMP-2, 120 nM for MMP-3, 10.8 nM for MMP-8, 18 nM for MMP-9, and 0.56 nM for MMP-13. This compound is essential for exploring the roles of MMPs in various biological processes including tissue remodeling, wound healing, and cancer metastasis. XL-784 free base can therefore serve as a valuable tool in pharmacological studies and drug development targeting MMP-related diseases.
RO314724 is a selective inhibitor of matrix metalloproteinase-1 (MMP-1), targeting the catalytic zinc ion within its active site to form a stable complex. This compound exhibits potent biological activity in suppressing MMP-1 activity, making it a valuable tool for research into conditions such as osteoarthritis, where MMP-1 plays a significant role in tissue degradation.
SC-77964 is a potent and selective matrix metalloprotease (MMP) inhibitor with significant activity against MMP-2, MMP-9, and MMP-13, exhibiting IC50 values lower than 0.1 nM. This compound is effective for investigating mechanisms associated with cancer and inflammation, particularly in the context of melanoma research. Its orally active nature makes it a valuable tool for in vivo studies targeting MMP-related pathways.
Out of stock
All 3 sizes